SALT LAKE CITY — Wasatch BioLabs (WBL), a leader in native, long-read sequencing and epigenomic analysis, today announced a co-marketing agreement with Agilent Technologies to support the adoption of its Direct Targeted Methylation Sequencing (dTMS) platform. The collaboration brings together Agilent’s enrichment chemistries—SureSelect for genomic DNA and Avida for cell-free DNA—and WBL’s proprietary Oxford Nanopore-based native-read workflow, expanding […]

Collaboration pairs robust synthetic biology platform with massive scale single cell sequencing to overcome long-standing challenges in variant mapping SEATTLE — Parse Biosciences, the leading provider of scalable and accessible single cell sequencing solutions, today announced a collaboration with Codebreaker Labs to develop and validate a breakthrough platform capable of testing thousands of genetic variants […]

CAMBRIDGE, Mass. & SAN DIEGO — Quantori, a leading provider of digital transformation services and technology for the life sciences and healthcare industries, and Expert Systems, a pioneer in next-generation AI solutions, today announced a strategic collaboration focused on developing and commercializing foundational predictive models for pharmaceutical research and development. This partnership will integrate Expert Systems’ […]

CAMBRIDGE, Mass. — TileDB has announced the launch of TileDB Carrara, the omnimodal data intelligence platform, as a Snowflake Connected App for Healthcare & Life Sciences. This integration enables organizations to unify complex scientific and multimodal data—including genomics, proteomics, medical imaging, and documents—that live in both TileDB and Snowflake, providing a unified view and streamlined […]

BD FACSDiscover™ A8 Cell Analyzer to Enable Investigation of 30+ Cellular Characteristics to Capture Key Biological Insights and Support Planned 1,000-Person Immune Profiling Study FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a strategic collaboration with the Institute for Immunology and Immune Health (I3H) […]

Partnership expands BC Platforms’ global patient catchment to include an additional 48 million patient lives across Asia, the Middle East, Africa, and Latin America ZURICH — BC Platforms, a global leader in healthcare data technology and analytics, today announced a major expansion of its global data capabilities through a strategic partnership with GeneVault Lifesciences™️, a data intelligence […]

Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and GMP-manufactured culture media KAWASAKI, Japan and SANTA ANA, California. USA – Chitose Laboratory Corp., (CHITOSE), a leading company of the bioeconomy and provider of advanced cell line development services, and FUJIFILM Biosciences Inc., a global leader in the innovation and manufacture of cell culture solutions for […]

The WEHI Centre for Dynamic Imaging becomes first ZEISS partner in Melbourne Area Jena, Melbourne ZEISS Research Microscopy Solutions ZEISS announces the launch of the labs@location program in Australia. The WEHI (Walter and Eliza Hall Institute of Medical Research) Centre for Dynamic Imaging becomes the first ZEISS labs@location partner in Australia. Mastering disease through discovery […]

Strategic collaboration integrates next-generation SPAD-based image sensor into Renishaw’s new Raman spectroscopy module to allow measurements of highly fluorescent samples Edinburgh, UK – Image-sensor innovator Singular Photonics today announced a major milestone in its strategic collaboration with Renishaw, a global leader in metrology and analytical instrumentation. The companies have been co-developing next-generation spectroscopy capabilities powered by Singular’s new suite […]

Non-exclusive license for Optimer® binder targeting the next-generation sequencing market Aptamer Group plc, the developer of next-generation synthetic binders for the life sciences industry, is pleased to announce a first licensing agreement with Twist Bioscience, a leading synthetic biology and genomics company. Under the terms of the agreement, Aptamer has granted Twist Bioscience a non-exclusive […]